Vanguard Group
RMD icon

Vanguard Group’s ResMed RMD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.84B Buy
18,746,925
+253,223
+1% +$65.3M 0.08% 253
2025
Q1
$4.14B Buy
18,493,702
+320,240
+2% +$71.7M 0.07% 262
2024
Q4
$4.16B Buy
18,173,462
+160,590
+0.9% +$36.7M 0.07% 263
2024
Q3
$4.4B Buy
18,012,872
+112,570
+0.6% +$27.5M 0.08% 251
2024
Q2
$3.43B Buy
17,900,302
+130,536
+0.7% +$25M 0.07% 300
2024
Q1
$3.52B Buy
17,769,766
+26,309
+0.1% +$5.21M 0.07% 294
2023
Q4
$3.05B Buy
17,743,457
+173,635
+1% +$29.9M 0.07% 304
2023
Q3
$2.6B Sell
17,569,822
-6,801
-0% -$1.01M 0.06% 316
2023
Q2
$3.84B Buy
17,576,623
+60,070
+0.3% +$13.1M 0.09% 218
2023
Q1
$3.84B Buy
17,516,553
+1,010,935
+6% +$221M 0.1% 204
2022
Q4
$3.44B Buy
16,505,618
+243,774
+1% +$50.7M 0.09% 224
2022
Q3
$3.55B Buy
16,261,844
+199,805
+1% +$43.6M 0.1% 193
2022
Q2
$3.37B Buy
16,062,039
+194,582
+1% +$40.8M 0.09% 210
2022
Q1
$3.85B Buy
15,867,457
+254,208
+2% +$61.6M 0.09% 218
2021
Q4
$4.07B Buy
15,613,249
+55,424
+0.4% +$14.4M 0.09% 208
2021
Q3
$4.1B Buy
15,557,825
+142,021
+0.9% +$37.4M 0.1% 179
2021
Q2
$3.8B Sell
15,415,804
-70,054
-0.5% -$17.3M 0.09% 205
2021
Q1
$3B Buy
15,485,858
+46,014
+0.3% +$8.93M 0.08% 252
2020
Q4
$3.28B Sell
15,439,844
-204,669
-1% -$43.5M 0.1% 202
2020
Q3
$2.68B Sell
15,644,513
-348,334
-2% -$59.7M 0.09% 215
2020
Q2
$3.07B Sell
15,992,847
-137,607
-0.9% -$26.4M 0.11% 169
2020
Q1
$2.38B Buy
16,130,454
+340,161
+2% +$50.1M 0.1% 184
2019
Q4
$2.45B Buy
15,790,293
+143,324
+0.9% +$22.2M 0.08% 242
2019
Q3
$2.11B Buy
15,646,969
+319,737
+2% +$43.2M 0.08% 269
2019
Q2
$1.87B Buy
15,327,232
+212,459
+1% +$25.9M 0.07% 303
2019
Q1
$1.57B Buy
15,114,773
+249,539
+2% +$25.9M 0.06% 345
2018
Q4
$1.69B Buy
14,865,234
+297,429
+2% +$33.9M 0.08% 273
2018
Q3
$1.68B Buy
14,567,805
+69,129
+0.5% +$7.97M 0.07% 331
2018
Q2
$1.5B Buy
14,498,676
+38,860
+0.3% +$4.03M 0.06% 359
2018
Q1
$1.42B Buy
14,459,816
+178,525
+1% +$17.6M 0.06% 369
2017
Q4
$1.21B Buy
14,281,291
+141,115
+1% +$12M 0.05% 419
2017
Q3
$1.09B Buy
14,140,176
+2,225,505
+19% +$171M 0.05% 434
2017
Q2
$928M Buy
11,914,671
+378,964
+3% +$29.5M 0.05% 471
2017
Q1
$830M Buy
11,535,707
+508,392
+5% +$36.6M 0.04% 504
2016
Q4
$684M Buy
11,027,315
+341,179
+3% +$21.2M 0.04% 538
2016
Q3
$692M Sell
10,686,136
-993,189
-9% -$64.3M 0.04% 517
2016
Q2
$738M Buy
11,679,325
+1,114,598
+11% +$70.5M 0.05% 471
2016
Q1
$611M Buy
10,564,727
+320,341
+3% +$18.5M 0.04% 515
2015
Q4
$550M Buy
10,244,386
+212,360
+2% +$11.4M 0.04% 536
2015
Q3
$511M Buy
10,032,026
+160,672
+2% +$8.19M 0.04% 548
2015
Q2
$556M Buy
9,871,354
+353,609
+4% +$19.9M 0.04% 547
2015
Q1
$683M Buy
9,517,745
+606,909
+7% +$43.6M 0.05% 463
2014
Q4
$500M Buy
8,910,836
+33,419
+0.4% +$1.87M 0.04% 548
2014
Q3
$437M Sell
8,877,417
-79,605
-0.9% -$3.92M 0.03% 558
2014
Q2
$453M Buy
8,957,022
+127,127
+1% +$6.44M 0.04% 549
2014
Q1
$395M Buy
8,829,895
+218,725
+3% +$9.77M 0.03% 585
2013
Q4
$405M Buy
8,611,170
+55,224
+0.6% +$2.6M 0.04% 555
2013
Q3
$452M Buy
8,555,946
+93,050
+1% +$4.91M 0.04% 482
2013
Q2
$382M Buy
+8,462,896
New +$382M 0.04% 509